期刊文献+

经皮冠状动脉介入治疗对缺血性心肌病患者左心室功能的影响 被引量:10

The effect of percutaneous coronary intervention on left ventricular function in patients with ischemic cardiomyopathy
下载PDF
导出
摘要 目的 探讨经皮冠状动脉介入(PCI)治疗对缺血性心肌病(ICM)患者左心室功能的影响.方法 将65例ICM患者随机分为PCI治疗组(32例)和药物治疗组(33例).PCI治疗组接受PCI和药物治疗;药物治疗组接受单纯药物治疗.随访1年,6和12个月时行心脏超声心动图检查,比较2组患者左心室舒张末容积(LVEDV)和左心室射血分数(LVEF)以及1年心血管事件发生情况.结果 PCI治疗组左心室功能改善优于药物治疗组[LVEF:治疗后6个月(38.0±2.4)%比(36.0±2.8)%,治疗后12个月(43.0±2.1)%比(40.0±2.5)%,P<0.05],PCI治疗组1年内急性心肌梗死、急性左心衰竭、心源性死亡以及因心功能不全和/或严重心肌缺血再次住院发生率低于药物治疗组[分别为6.2%比24.2%,9.4%比30.3%,3.1%比18.2%,18.7%比54.5%,均P<0.05].结论 PCI对ICM治疗有效,与单纯药物治疗比较,PCI加药物治疗能更有效地改善患者左心室功能及减少心血管事件发生. Objective To investigate the effect of percutaneous coronary intervention (PCI) on left ventricular function of patients with ischemic cardiomyopathy. Methods The 65 patients with ischemic cardiomyopathy were divided into PCI group(32 cases) and medicine group(33 cases). PCI group accepted PCI and medicine, medicine group accepted medicine only. They were followed up for one year. Transthoracic eahocardiography (TTE) in sixth and twelfth months were examined. The LVEDV, LVEF and cardiovascular events in one year between two groups were compared. Results The improvement of left ventricular function in PCI group was better than that in medicine group. [LVEF:sixth month after treatment(38.0±2.4)% vs (36.0±2.8)%,twelfth month(43.0± 2.1)% vs (40.0±2.5)%,P〈0.05]The incidence rates of the events of acute myocardial infarction,acute left heart failure, cardiac death, rehospitalization due to cardiac insufficiency or severe myocardiac ischemic in PCI group were lower than those in medicine group in one year[6.2% vs 24.2% ,9.4% vs 30. 3% ,3.1% vs 18.2% ,18.7% vs 54.5% ,P〈0.05]. Conclusions It is effective to treat the ischemic cardiomyopathy with PCI. The PCI combined with medicine is superior to medicine only in improving left ventricular function and decreasing cardiovascular events in ischemic cardiomyopathy.
作者 何劲松
出处 《中国医药》 2011年第8期908-909,共2页 China Medicine
关键词 缺血性心肌病 血管成形术 经腔 经皮冠状动脉 左心室功能 Ischemic cardiomyopathy Angioplasty,transluminal,percutaneous cornorary Left ventricular function
  • 相关文献

参考文献8

二级参考文献50

  • 1崔广凯,潘宗科,李晓东,马淑梅.心梗后心功能变化与心梗后缺血性心肌病的关系[J].现代康复,1999,3(6):742-743. 被引量:2
  • 2李树仁.缺血性心肌病的发病机制[J].临床荟萃,1995,10(6):243-244. 被引量:2
  • 3陈灏珠.实用内科学(第10版)[M].北京:人民卫生出版社,1997.1410-1413.
  • 4陈灏珠.实用内科学[M](第10版)[M].北京:人民卫生出版社,1997.835-838.
  • 5于全俊 见:陈在嘉 高润霖 主编.缺血性心肌病的治疗与预后[A].见:陈在嘉,高润霖,主编.冠心病.第2版[C].北京:人民卫生出版社,2003.1136-1139.
  • 6Rodkey SM, Ratliff NB, Young JB. Cardiomyopathy and myocardial failure. In: Topol EJ, ed. Coprehensive cardiovarscular medicine. Philadelphia: Lippincott-Raven Publishers,1998.2599-2601.
  • 7Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices:summary article. Circulation,2002,15:2145-2161.
  • 8Smith SC Jr, Dove JT, Jacobs AK, et al.ACC/AHA guidelines of percutaneous coronary interventions revision of the 1993 PTCA guidelines: a report of the American college of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). Circulation,2001,103:3019-3041.
  • 9Senior R, Kaul S, Lahiri A. Myocardial viability predicts regression of remodeling following revascularisation compared to medical therapy in ischemic cardiomypathy. Eur Heart J,2000,Suppl:21.
  • 10Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure:the Multicenter Insync Randomized Clinical Evaluation(MIRACLE). J Card Fail,2000, 6:369-380.

共引文献51

同被引文献62

  • 1韩雅玲,臧红云,王冬梅,荆全民,王守力,王祖禄.冠状动脉介入治疗联合心脏再同步化治疗缺血性心肌病顽固性心力衰竭[J].中华心血管病杂志,2005,33(1):17-21. 被引量:30
  • 2荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量:98
  • 3陆再英,钟南山.内科学.7版.北京:人民卫生出版社,2008,1:267-294.
  • 4陆再英,钟南山.内科学[M].7版北京:人民卫生出版社.2008:394.
  • 5段文昌,耿珊,杨光,等.经皮冠状动脉介入治疗对老年缺血性心肌病心功能和预后的影响[J].中国老年多器官疾病杂志,2009,8(5):445-447.
  • 6刘昌喜,李屏,吴立荣,等.急诊PCI对急性ST段抬高型心肌梗死患者左心室功能的影响[J].贵阳医学院学报,2011,36(1):26-29.
  • 7何东明,黄军章,仇昌智,等.缺血性心肌病86例临床分析[J].中外健康文摘,2012,5(9):22.
  • 8Dincer I, Ongun A,Turhan S, et al .Association between the dosage and duration of statin treatment with coronary collateral development [J]. Coron Artery Dis, 2006,17 (6): 561.
  • 9Rodkey SM,Ratliff NB,Young JB. Cardiomyopathy and myocardi-al failure//Comprehensive cardiovascular medicine, Topol EJ.Philadelphia : Lippincott-Raven Publishers, 1998:2599-2601.
  • 10Cleland JG, Pennell DJ, Ray SG, et al. Myocardial viability as adeterminant of the ejection fraction response to carvedilol in patientswith heart failure ( CHRISTMAS trial) : randomised controlled tri-al. Lancet, 2003,362(9377) : 14-21.

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部